Department of Surgery, Transplantation and Interventional Gastroenterology, Semmelweis University, Hepato-Pancreatico-Biliary (HPB) Surgical Research Center Hungary, Budapest, Hungary.
Department of Medical Biochemistry, Semmelweis University, Budapest, Hungary.
PLoS One. 2022 Jul 14;17(7):e0271606. doi: 10.1371/journal.pone.0271606. eCollection 2022.
Associating Liver Partition and Portal vein ligation for Staged hepatectomy (ALPPS) is a modification of two-stage hepatectomy profitable for patients with inoperable hepatic tumors by standard techniques. Unfortunately, initially poor postoperative outcome was associated with ALPPS, in which mitochondrial dysfunction played an essential role. Inhibition of cyclophilins has been already proposed to be efficient as a mitochondrial therapy in liver diseases. To investigate the effect of Cyclophilin D (CypD) depletion on mitochondrial function, biogenesis and liver regeneration following ALPPS a CypD knockout (KO) mice model was created.
Male wild type (WT) (n = 30) and CypD KO (n = 30) mice underwent ALPPS procedure. Animals were terminated pre-operatively and 24, 48, 72 or 168 h after the operation. Mitochondrial functional studies and proteomic analysis were performed. Regeneration rate and mitotic activity were assessed.
The CypD KO group displayed improved mitochondrial function, as both ATP production (P < 0.001) and oxygen consumption (P < 0.05) were increased compared to the WT group. The level of mitochondrial biogenesis coordinator peroxisome proliferator-activated receptor γ co-activator 1-α (PGC1-α) was also elevated in the CypD KO group (P < 0.001), which resulted in the induction of the mitochondrial oxidative phosphorylation system. Liver growth increased in the CypD KO group compared to the WT group (P < 0.001).
Our study demonstrates the beneficial effect of CypD depletion on the mitochondrial vulnerability following ALPPS. Based on our results we propose that CypD inhibition should be further investigated as a possible mitochondrial therapy following ALPPS.
联合肝脏离断和门静脉结扎的分阶段肝切除术(ALPPS)是对标准技术无法手术切除的肝肿瘤患者有利的两阶段肝切除术的改良。不幸的是,最初与 ALPPS 相关的术后结果较差,其中线粒体功能障碍起着重要作用。已经提出抑制亲环蛋白作为肝脏疾病的一种有效的线粒体治疗。为了研究 CypD 耗竭对 ALPPS 后线粒体功能、生物发生和肝再生的影响,创建了 CypD 敲除(KO)小鼠模型。
雄性野生型(WT)(n = 30)和 CypD KO(n = 30)小鼠接受了 ALPPS 手术。动物在术前和手术后 24、48、72 或 168 小时终止。进行线粒体功能研究和蛋白质组分析。评估再生率和有丝分裂活性。
与 WT 组相比,CypD KO 组的线粒体功能得到改善,ATP 产生(P < 0.001)和耗氧量(P < 0.05)均增加。CypD KO 组的线粒体生物发生协调因子过氧化物酶体增殖物激活受体γ共激活因子 1-α(PGC1-α)水平也升高(P < 0.001),导致线粒体氧化磷酸化系统的诱导。与 WT 组相比,CypD KO 组的肝脏生长增加(P < 0.001)。
我们的研究表明 CypD 耗竭对 ALPPS 后线粒体脆弱性具有有益作用。基于我们的结果,我们提出 CypD 抑制应作为 ALPPS 后的一种可能的线粒体治疗进一步研究。